MTI Ltd. (JP:9438)
:9438
Want to see JP:9438 full AI Analyst Report?
Top Page
MTI Ltd.
(9438)
Select Model
Select Model
Rating:71Outperform
Price Target:
¥665.00
▼(-7.77% Downside)
Action:ReiteratedDate:02/14/26
The score is driven primarily by strong financial performance (high margins, low leverage, and improved cash flow), partially offset by weak technicals (trading below major moving averages with negative MACD and a low RSI). Valuation is supportive with a reasonable P/E and a mid-level dividend yield.
Positive Factors
High gross and net margins
Sustained gross margin of 74.3% and net margin of 11.4% indicate durable product-level economics from digital content and subscription services. High margins provide ongoing cash to fund product development, marketing and allow resilience to cost shocks over the next several quarters.
Negative Factors
Slowing revenue growth
Revenue growth decelerated to +1.61% in the latest year, which is a structural concern for a subscription-led digital content firm. Slowing top-line expansion can limit network effects, reduce leverage on fixed costs, and constrain long-term margin expansion and scalability.
Read all positive and negative factors
Positive Factors
Negative Factors
High gross and net margins
Sustained gross margin of 74.3% and net margin of 11.4% indicate durable product-level economics from digital content and subscription services. High margins provide ongoing cash to fund product development, marketing and allow resilience to cost shocks over the next several quarters.
Read all positive factors
MTI Ltd. (9438) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥32.42B
Dividend Yield2.58%
Average Volume (3M)62.04K
Price to Earnings (P/E)16.7
Beta (1Y)0.41
Revenue Growth7.40%
EPS Growth46.04%
CountryJP
Employees1,184
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)10.87
Shares Outstanding60,435,200
10 Day Avg. Volume33,460
30 Day Avg. Volume62,043
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)2.31
Price to Sales (P/S)1.42
P/FCF Ratio7.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)34.2
Revenue Forecast (FY)¥31.50B
MTI Ltd. Business Overview & Revenue Model
Company Description
MTI Ltd. (9438) is a publicly traded company primarily engaged in the development and provision of innovative technology solutions, focusing on sectors such as telecommunications, information technology, and consumer electronics. The company speci...
How the Company Makes Money
MTI Ltd. generates revenue through the subscription-based model for its digital content and services. Users subscribe to the company's platforms for access to premium features, such as health management tools, music streaming, and e-book libraries...
MTI Ltd. Financial Statement Overview
Summary
Income Statement
82
Very Positive
Balance Sheet
78
Positive
Cash Flow
75
Positive
| Breakdown | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 29.91B | 27.67B | 26.80B | 26.48B | 25.74B |
| Gross Profit | 22.22B | 20.40B | 18.37B | 18.69B | 18.74B |
| EBITDA | 6.02B | 5.17B | 2.91B | 1.44B | 2.45B |
| Net Income | 3.40B | 2.36B | 753.22M | -930.48M | -1.16B |
Balance Sheet | |||||
| Total Assets | 33.35B | 29.70B | 29.17B | 29.28B | 31.91B |
| Cash, Cash Equivalents and Short-Term Investments | 17.82B | 14.83B | 13.72B | 12.10B | 15.54B |
| Total Debt | 1.69B | 2.43B | 3.18B | 3.93B | 2.88B |
| Total Liabilities | 10.90B | 10.55B | 11.58B | 11.40B | 10.67B |
| Stockholders Equity | 18.41B | 15.47B | 14.01B | 14.18B | 17.59B |
Cash Flow | |||||
| Free Cash Flow | 5.58B | 2.74B | 3.60B | -3.59B | 1.74B |
| Operating Cash Flow | 5.66B | 4.13B | 4.76B | -1.39B | 3.52B |
| Investing Cash Flow | -1.02B | -1.37B | -1.35B | -2.46B | -2.00B |
| Financing Cash Flow | -1.63B | -1.64B | -1.78B | 343.54M | 649.18M |
MTI Ltd. Technical Analysis
Negative
721.00
Price Trends
655.01
Negative
690.63
Negative
757.27
Negative
Market Momentum
-11.43
Negative
43.89
Neutral
16.67
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9438, the sentiment is Negative. The current price of 721 is above the 20-day moving average (MA) of 627.50, above the 50-day MA of 655.01, and below the 200-day MA of 757.27, indicating a bearish trend. The MACD of -11.43 indicates Negative momentum. The RSI at 43.89 is Neutral, neither overbought nor oversold. The STOCH value of 16.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:9438.
MTI Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥32.42B | 16.74 | ― | 2.58% | 7.40% | 46.04% | |
70 Outperform | ¥1.03T | 18.91 | 12.15% | 1.01% | 29.62% | 20.49% | |
63 Neutral | ¥65.67B | 228.03 | ― | 0.39% | 10.70% | ― | |
63 Neutral | ¥220.20B | 26.76 | ― | 0.43% | 16.95% | 53.70% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥72.67B | 77.03 | 5.76% | ― | 25.54% | -64.88% | |
44 Neutral | ¥2.49B | -4.28 | ― | ― | 20.39% | 34.43% |
* Healthcare Sector Average
JP:9438
MTI Ltd.
599.00
-168.27
-21.93%
JP:2413
M3
1,520.00
-232.56
-13.27%
JP:4480
Medley
2,232.00
-1,108.00
-33.17%
JP:3902
Medical Data Vision Co.Ltd.
1,684.00
1,249.00
287.13%
JP:4438
Welby Inc.
308.00
-28.00
-8.33%
JP:4483
JMDC Inc.
3,335.00
188.31
5.98%
MTI Ltd. Corporate Events
MTI completes restricted stock share issuance for management remuneration
Feb 20, 2026
MTI Ltd. has completed payment procedures for the issuance of 52,400 new common shares as restricted stock remuneration to its internal directors and executive officers. The shares, priced at 734 yen each for a total of about 38.46 million yen, fo...
MTI Sets Out Q1 FY2026 Results and DX Growth Strategy
Feb 10, 2026
MTI Ltd. released materials for its Q1 FY2026 financial results briefing, outlining consolidated profit and loss, SGA trends, balance sheet data, and segment performance. The company highlighted its earnings forecast for FY2026 and detailed the st...
MTI Books Higher Q1 Revenue, Keeps Fiscal 2026 Outlook and Raises Dividend
Feb 9, 2026
MTI Ltd. reported consolidated net sales of ¥7.77 billion for the quarter ended Dec. 31, 2025, up 6.9% year on year, with operating income rising 16.4% to ¥835 million and profit attributable to owners of parent edging up 2.4% to ¥6...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.